Read the latest news about TRIBEKA, an initiative driven whose mission is to generate an open access neuroimaging platform that allows to offer widely characterized information to advance the design of new treatments for Alzheimer's disesae and other neurodegenerative diseases.
Data of the Study Alfa is now available, upon request, on the integrated online research platform launched by the Alzheimer’s Association.
El consorcio está formado por investigadores de Barcelona, Edimburgo y Estocolomo, y cuenta con un presupuesto de 2,1 millones de euros.
BBRC researchers made 4 oral presentations and exhibited 7 posters